Clinical Trials
5 trialsNCT00111384 2026-06-05
Study of Disease Severity in Adults With Neurofibromatosis Type 1 (NF1)
National Institutes of Health Clinical Center (CC)
Completed
NCT00314119 2026-06-05
Natural History and Biology of Skin Neurofibromas in Neurofibromatosis Type 1
National Institutes of Health Clinical Center (CC)
Completed
NCT04481048 2026-06-05
DoDNAC
Children's Hospital Medical Center, Cincinnati
Phase 2 Completed
NCT03433183 2026-05-27
SARC031: MEK Inhibitor Selumetinib (AZD6244) in Combination With the mTOR Inhibitor Sirolimus for Patients With Malignant Peripheral Nerve Sheath Tumors
Sarcoma Alliance for Research through Collaboration
Phase 2 Completed
NCT04481035 2026-04-21
NF1NAC
Children's Hospital Medical Center, Cincinnati
Phase 2 Completed